VIATRIS is a new kind of healthcare company, formed in 2020 through the combination of Mylan and Upjohn. They are committed to providing access to medicines, advancing sustainable operations, developing innovative solutions and leveraging their collective expertise to improve patient outcomes.
Their mission is to empower people worldwide to live healthier at every stage of life by expanding access to medicines regardless of geography or circumstance; advancing responsible, sustainable operations and targeted innovation to improve patient health; and leveraging its collective expertise to connect more people to more products and services.
In the UK, they are the second largest pharmaceutical company with a portfolio of nearly 300 products across a broad range of therapeutic areas which deliver significant value to the NHS and for UK patients. Their portfolio of medicines cover every stage of life and treat more than 6 million patients annually.
With a 500 strong team of talented and dedicated individuals working across four sites they are committed to serving patients, having a positive impact on the environment and supporting their local communities.
Learn more at www.viatris.co.uk